| SDGs In Play: #17 Partnerships For The Goals |
|
|
|
| Partnership and cooperation are essential for achieving the Global Goals. The international community has encouraged the development of partnerships between stakeholders, including business, to achieve common goals. It is only by forging partnerships that leverage the core competencies of all partners that the ambition of the SDGs can be achieved.
Companies are major players among SDG stakeholders, offering expertise, experience, resources, access to knowledge, and capabilities to innovate. But, companies cannot create transformative change acting alone. Business may not fully take account of all voices and be aware of all areas of need; and they may not have access to the best available knowledge. |
| | Read More |
|
|
| COMMITTING TO SDG #17, CONSIDER THESE: |
|
|
|
1. Intentionality - Is your company committed to supporting the achievement of Goal 17? Have you developed a holistic strategy that reflects this commitment, covering end-to-end operation and the wider community?
- Are you committed to learning from your actions and do you have processes in place to improve them accordingly?
- Is your strategy supported by the highest levels of management, including the Board of Directors.
2. Ambition - Do your actions achieve long-term outcomes that greatly exceed those resulting from current industry practice?
- Are your actions aligned with what is needed to achieve Goal 17?
3. Consistency - Is support for Goal 17 embedded across all organizational functions?
- Are staff and board incentives aligned with achieving Goal 17?
4. Collaboration - Do you proactively look for opportunities to partner with Governments, UN agencies, suppliers, civil society organizations, industry peers and other stakeholders to inform how to advance Goal 17?
5. Accountability - Do you publicly express your commitment to advance Goal 17?
- Do you identify, monitor, and report on impacts, including potentially adverse impacts?
- Do you mitigate risks associated with your action?
- Do you remediate negative impacts associated with this action?
- Do you engage stakeholders in a meaningful way?
|
|
AMCHAM Members share their actions to contribute towards this SDG. |
|
| For nearly 20 years, Novartis has broadened oncology drug access through the Glivec® International Patient Assistance Program (GIPAP) worldwide. GIPAP is one of the most innovative patient assistance programs ever implemented on a global scale. Through GIPAP, Novartis provides imatinib at no cost to eligible patients in lower-income countries where there may not be access to reimbursement or funding mechanisms and to those unable to pay for the medication. |
| | Read More |
|
|
American Malaysian Chamber of Commerce
Level 10, Bangunan Faber Imperial Court, Jalan Sultan Ismail,
Kuala Lumpur 50250, Malaysia
You are receiving this e-mail monthly because you are subscribed to the AMCHAM Malaysia newsletter
Copyright © 2021 AMCHAM Malaysia, All rights reserved. |
|
|
